Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | Dyne Therapeutics, Inc. DYN |
BlackRock Inc. BLK |
6,577,879 5.800% |
-1,216,338 (-15.61%) |
Filing History |
| 2025-02-14 12:22 pm Purchase |
2024-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
JANUS HENDERSON GROUP PLC JHG |
7,379,309 7.300% |
566,146 (+8.31%) |
Filing History |
| 2025-02-14 09:00 am Sale |
2024-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
RTW Investments, LP | 5,218,641 5.100% |
-1,600,000 (-23.47%) |
Filing History |
| 2025-02-12 09:28 am Sale |
2024-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
FMR LLC | 7,996,931 7.900% |
-1,029,766 (-11.41%) |
Filing History |
| 2025-02-03 5:07 pm Purchase |
2025-01-31 | 13G | Dyne Therapeutics, Inc. DYN |
Point72 Asset Management, L.P. | 5,196,597 5.100% |
5,196,597 (New Position) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
RA Capital Management, L.P. | 6,381,144 6.400% |
1,167,483 (+22.39%) |
Filing History |
| 2024-11-14 4:32 pm Sale |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
Atlas Venture Fund XI, L.P. | 5,714,057 5.700% |
-1,628,026 (-22.17%) |
Filing History |
| 2024-11-14 4:23 pm Sale |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 2,960,081 3.000% |
-112,506 (-3.66%) |
Filing History |
| 2024-11-14 10:28 am Purchase |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
JANUS HENDERSON GROUP PLC JHG |
6,813,163 6.800% |
6,813,163 (New Position) |
Filing History |
| 2024-11-14 09:27 am Purchase |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 3,282,000 3.270% |
1,282,000 (+64.10%) |
Filing History |
| 2024-11-14 07:00 am Sale |
2024-09-30 | 13G | Replimune Group, Inc. REPL |
Forbion Capital Fund IV Cooperatief U.A. | 5,795,364 5.800% |
-335,715 (-5.48%) |
Filing History |
| 2024-11-14 06:34 am Purchase |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
RTW Investments, LP | 6,818,641 6.800% |
6,818,641 (New Position) |
Filing History |
| 2024-11-12 2:20 pm Unchanged |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
The Vanguard Group | 6,864,137 6.830% |
0 (Unchanged) |
Filing History |
| 2024-11-12 09:55 am Purchase |
2024-11-08 | 13G | Dyne Therapeutics, Inc. DYN |
FMR LLC | 9,026,697 8.990% |
9,026,697 (New Position) |
Filing History |
| 2024-11-08 5:31 pm Unchanged |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
BlackRock Inc. BLK |
7,794,217 7.800% |
0 (Unchanged) |
Filing History |
| 2024-11-04 10:20 am Purchase |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
The Vanguard Group | 6,864,137 6.830% |
6,864,137 (New Position) |
Filing History |
| 2024-10-22 3:24 pm Purchase |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
BlackRock Inc. BLK |
7,794,217 7.800% |
4,005,535 (+105.72%) |
Filing History |
| 2024-04-04 7:04 pm Purchase |
2024-03-25 | 13G | Dyne Therapeutics, Inc. DYN |
RA Capital Management, L.P. | 5,213,661 6.400% |
5,213,661 (New Position) |
Filing History |
| 2024-02-14 4:57 pm Purchase |
2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Citadel Advisors LLC | 3,072,587 5.000% |
91,263 (+3.06%) |
Filing History |
| 2024-02-14 08:39 am Sale |
2023-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
Deep Track Capital, LP | 2,000,000 3.260% |
-2,500,000 (-55.56%) |
Filing History |